Liposomes are spherical vesicles made of phospholipid bilayers that can encapsulate hydrophilic or hydrophobic drugs. There are several methods for manufacturing liposomes including mechanical dispersion methods like film hydration and sonication. Film hydration involves dissolving lipids in an organic solvent to form a thin film, removing the solvent, then hydrating the film. The hydrated lipid sheets self-close to form multilamellar vesicles. Several factors must be considered for liposome preparation including lipid selection, phase transition temperature, charge, and cholesterol content. Liposomes can be classified based on size, lamellarity, surface properties, and method of preparation.
2. Introduction
Advantages & Disadvantages
Classification
Manufacturing of liposomes
Liposome characterization and control
Stability consideration for liposomal formulations
Regulatory science of liposome drug products
Drug release from liposomes
Applications
Recent innovations
Approved liposome products
Contents
3. • The word liposome derives from two Greek words: lipo ("fat") and soma ("body");
it is so named because its composition is primarily of phospholipid.
• The preparation of liposomes, with entrapped solutes, was demonstrated for the
first time in 1965 by Prof. A.D. Bangham of the Cambridge University (UK).
• They were discovered when Bangham and R. W. Horne were testing the institute's
new electron microscope by adding negative stain to dry phospholipids.
Introduction
4. • Liposomes are microscopic spheres made from fatty materials, predominantly
phospholipids.
• Made up of one or more concentric lipid bilayers, and range in size from 50
nanometers to several micrometers in diameter
Definition
5. Suitable for delivery of hydrophobic, hydrophilic and amphipatic drugs & agents
Chemically and physically well characterized entities
Biocompatible
Suitable for controlled release
Suitable to give localized action in particular tissues.
Suitable to administer via various routes
Advantages
6. Disadvantages
Less stability.
Batch to batch variation.
Difficult in large scale manufacturing and sterilization.
High production cost.
Once administered, liposomes can not be removed.
Some times phospholipids undergoes hydrolysis and oxidation
reactions
Leakage and fusion.
Allergic reaction may occur with liposomal constituents.
7. Classification based on size of liposomes
Classification based on method of preparation
Classification based on composition and in vivo application
Classification
8. Small unilamellar vesicles
Medium sized unilamellar vesicles
Large unilamellar vesicles
Giant unilamellar vesicles
Unilamellar vesicles
Oligolamellar vesicles
Multilamellar large vesicles
Multivesicular vesicles
Classification based on size
9. Vesicles prepared by extrusion method.
Vesicles prepared by French press.
Vesicles prepared by fusion.
Vesicles prepared by reverse phase evaporation.
Frozen and thawed MLV.
Dehydration and rehydration vesicles.
Stable plurilamellar vesicles.
Classification based on method of preparation
11. • Inhibition of the rapid uptake of liposomes by the
reticulo-endothelial system (RES) and reduction of
the rate of drug leakage have resulted in long-
circulating liposomal drug systems with valuable
pharmacologic properties.
• Particularly, the coating of liposomes with
polyethylene-glycol (PEG) confers optimal
protection to the vesicles from RES-mediated
clearance, while bilayer rigidification using high
Tm phospholipids reduces the rate of leakage of
liposome contents.
• These carrier systems display an improved
extravasation profile with enhanced localization in
tumors and possibly in other tissues, such as skin.
Long circulating liposomes (Stealth Technology)
12. • An anti-cancer drug, doxorubicin, encapsulated
in small-sized (< 100nm diameter), PEG-coated
liposomes with a rigid bilayer shows a unique
pharmacokinetic pattern, characterized by
extremely long half-life, slow clearance, and
small volume of distribution.
• Liposome longevity in circulation correlates
positively with high drug levels in the
extracellular tumor fluid and with enhanced
therapeutic efficacy in a variety of tumor
models regardless of the site of tumor growth.
Long circulating liposomes (Stealth Technology) cont.
13. • Target specific ligands, such as antibodies,
immunoglobulins, lectins and
oligosaccharides attached to the surface
Targeted liposomes
14. • Cationic liposomes are prepared from at least
one cationic phospholipid. The positively
charged lipid bilayers can form complexes with
negatively charged nucleic acid by simple mixing.
• The resulting cationic liposomes-nucleic acid
complexes, called lipoplexes, are formed by a
combination of electrostatic attraction and
hydrophobic interaction and have been
extensively used as nonviral vectors for the
intracellular delivery of therapeutic genes.
• The nonviral vectors based on nanoparticles
(50–500 nm) were already tested to transport
plasmid DNA.
Cationic liposomes
15. Temperature sensitive liposome
The temperature-sensitivity of such liposomes allows the release of compounds entrapped
within the interior aqueous space of the liposome, and/or the release of compounds associated
with the lipid bilayer, at a target site that is either heated (as in the clinical procedure of
hyperthermia) or that is at an intrinsically higher temperature than the rest of the body (as in
inflammation).
Traditional temperature-sensitive liposomes require relatively high temperatures (42–45°C) to
induce drug release.
Temperatures in this range are not readily achievable throughout a tumor volume in the clinic
because of patient pain during heating and potential for normal tissue injury .In contrast, low
temperature-sensitive liposomes release their contents at 39–42°C.
16. pH sensitive liposome
These liposomes are stable at physiological pH (pH 7.4) but undergo destabilization and
acquire fusogenic properties under acidic conditions, thus leading to the release of their
aqueous contents.
The theory of pH-sensitive liposomes emerged from the reality that certain enveloped
viruses developed strategies to benefit from the acidification of the endosomal lumen to
infect cells, as well as from the observation that some pathological tissues (tumours,
inflamed and infected areas) exhibit an acidic environment as compared with normal
tissues .
17. pH sensitive liposome (cont.)
Different classes of pH-sensitive liposomes have been proposed in the literature, based
on the mechanism of triggering pH sensitivity.
The most commonly established hypothesis involves the blend of
phosphatidylethanolamine (PE) or its derivatives with compounds containing an acidic
group (e.g. carboxylic group) that acts as a stabilizer at neutral pH.
Contemporary studies describe the use of novel pH-sensitive lipids, synthetic fusogenic
peptides/ proteins either encapsulated or included in the lipid bilayer and attachment of
pH-sensitive polymers with liposomes.
21. Phase transition temperature
Stability
Charge
Lipid mixtures
Cholesterol
Source
Factors to be consider while selecting lipids
22. The Phase transition temperature (Tc) of phospholipids is a temperature at which
phospholipids transit from gel to liquid crystalline state.
Factors affecting Tc.
The nature of the polar head group. phosphatidylcholine (PC) and
phosphatidylglycerol (PG) with the same hydrocarbon chains have similar Tc, but
the corresponding phosphatidylethanolamine (PE), has a higher Tc. For example,
the Tc of Dipalmitoyl phosphatidylcholine (DPPC) and Dipalmitoyl
phosphatidylglycerol (DPPG) are both 41 C, whereas Dimyristoyl
phosphatidylethanolamine (DPPE) is 63 C, which is attributed to a stronger head
group interaction.
The length of the hydrocarbon chains. Phospholipids with longer hydrocarbon
chains have a higher Tc than those with shorter ones. For example, the Tc of
Distearoyl phosphatidylcholine (DSPC) is 55 C, and yet Dipalmitoyl
phosphatidylcholine (DPPC) is 41 C.
Phase transition temperature (Tc)
23. Factors affecting Tc.
The degree of saturation of the
hydrocarbon chains. For phospholipids
with the same head group and length of
aliphatic chain, high saturation in the
hydrocarbon chains increases the Tc. For
example, the Tc of DSPC is 55 C, whereas
Dioleoyl phosphatidylcholine (DOPC) is
20 C.
Purity. The low purity of phospholipids
widen the range of Tc. Naturally occurring
phospholipids are usually mixtures of
components having different length
hydrocarbon chains.
24. Stability
In order to make the drugs escape from being degraded into inactive compounds
by enzymes in lysosomes after endocytosis, usually pH sensitive liposomes are
prepared.
Dioleoyl phosphatidylethanolamine (DOPE) is usually selected to prepare pH-
sensitive liposomes, however, which is found to suffer from their difficulty to form
liposomes by themselves.
So in order to form stable liposomes, materials containing acidic groups must be
added to DOPE. The liposomes established by the above membrane materials
have pH-sensitivity, because at neutral pH, the fatty acid carboxyl ion can provide
effective electrostatic repulsion, which makes the liposomes stable at lamellar
phase, and at acidic pH, fatty acid carboxyl groups are protonated, causing the
formation of the HII phase, which makes the liposomes unstable and easy to
aggregate, fuse and release the contents.
25. • It has been observed that liposomes containing negatively charged phospholipids
such as phosphatydilserine (PS,) phosphatidylglycerol (PG) can be quickly
eliminated from the circulation system
Charge
• The main disadvantage of phospholipids as emulsifiers is that in the process of
emulsification, sterilization and storage.
• Natural lecithins are readily hydrolyzed to generate lysophospholipids which can lead to
hemolysis after intravenous injection. Phospholipid mixtures derived from the egg yolk
of birds and soybean have stronger emulsifying ability than single component.
• However, using purified lecithins can reduce the generation of lysophospholipids.
• The physical nature of lecithins and the resulting emulsion stability are changing a lot,
depending on the sources and the degrees of purification of the emulsifiers.
Lipid Mixtures
26. • Cholesterol is a membrane constituent widely found in biological systems which serves a unique
purpose of modulating membrane fluidity, elasticity, and permeability. It literally fills in the gaps
created by imperfect packing of other lipid.
• The presence of cholesterol exerts a profound influence on the properties of the lipid bilayers of the
liposomes. The addition of cholesterol to a fluid phase bilayer (mainly unsaturated lipids) decreases
its permeability to water.
• A liposome that is made from 100% unsaturated lipid in fluid phase can not hold its encapsulated
content and the encapsulated water soluble drugs will leak out over time and therefore the addition
of cholesterol is necessary in order to prevent the leakage of the encapsulated drug from the
liposomes. Liposomes made from 100% saturated lipids are leak-proof in the absence of the
cholesterol.
• One of the main reasons for addition of cholesterol to liposomes that are made from saturated lipids
is to decrease the phase transition temperature. The phase transition temperature of the mixture of
the lipids in the liposomes will be decreased, but not eliminated, by the addition of cholesterol.
Cholesterol
27. Synthetic and natural phospholipids have both advantages and disadvantages.
The advantages of synthetic phospholipids are that the property is relatively
stable, and purity is relatively high; the drawback is that the price is relatively
high.
However, the advantage of natural phospholipids is that the price is relatively
low; the disadvantages are that the purity is difficult to control, and the
nature is relatively unstable which can be metabolized to lysophospholipids in
the process of usage and storage.
So the source should be considered when choosing natural phospholipids to
prepare the liposomes.
For example, the content of unsaturated fatty acids in soybean phospholipids
is higher than that in egg yolk phospholipids. Therefore, it is difficult to obtain
quality controlled liposomes product using soybean lecithins.
Source
28. • Stress induced hydration of phospholipids
• Organization in to lamellar arrays
• Results in to budding of lipid bilayer leading to down sizing
SUV OLV
1. The budding theory
Mechanism of Vesicle Formation
29. • Liposomes are formed when
thin lipid films are hydrated
• The hydrated lipid sheets
detach during agitation and
self-close to form large,
multilamellar vesicles (LMV)
2.The bilayer phospholipids theory
31. Involves loading of the entrapped agents before or during the
manufacturing process
Passive loading techniques
Active or Remote loading techniques
Certain types of compounds with ionisable groups and those with both
lipid and water solubility, can be introduced into the liposomes after
the formation of the intact vesicle.
32. General Method of Preparation of Liposome
Lipid dissolve in organic solvent/ co-solvent
Remove organic solvent under vacuum
Film deposition
Solid lipid mixture is hydrated by using
aqueous buffer
Lipid spontaneously swell & hydrate
Liposome
Post hydration Vortexing, Sonication,
Freeze thawing & high pressure extrusion
33. MECHANICAL DISPERSION METHODS
Aqueous volume enclosed using this method usually 5-10%, which is a very small
proportion of total volume used for swelling .
Therefore large quantity of water –soluble compound are wasted during swelling .
On the other hand lipid soluble compound can be encapsulated to 100% efficacy,
provided they are not present in quantities that are greater than the structural
component of the membrane.
34. :
1.Lipid film hydration by hand shaking/non hand shaking
Step-1
Lipid mixture of different phospholipid and charge
components in chloroform: methanol solvent mixture
(2:1v/v) is prepared first and then introduced into a
round bottom flask with a ground glass neck.
This flask is then attached to a rotary evaporator and
rotated at 60 rpm. The organic solvent are evaporated
at about 30 degree Celsius or above the transition
temperature of the lipids used.
The nitrogen is introduced into the evaporator and
the pressure at the cylinder head is gradually raised
till there is no difference between inside and outside
the flask. The flask is then removed from the
evaporator and fixed on to the manifold of lyophilizer
to remove residual solvents.
35. Step-2 Hydration of lipid layer
After releasing the vacuum and removal from the lyophilizer, the flask is flushed
with nitrogen; 5 ml of saline phosphate buffer (containing solute to be
entrapped) is added.
The flask is attached to the evaporator again (flushed with N2) and rotated at
room temperature and pressure at the same speed or below 60 rpm. The flask
is left rotating for 30 minutes or until all lipid has been removed from the wall
of the flask and has given homogenous milky –white suspension free of visible
particles.
The suspension is allowed to stand for a further 2 hours at room temperature
or at a temperature above the transition temperature of the lipid in order to
complete the swelling process to give MLVs.
1.Lipid film hydration by hand shaking/non hand shaking (Cont.)
36. Method described by reeves and dowben in 1996 by which large unicellular vesicles (LUVv) can be formed
with higher entrapment volume.
The procedure differs from hand shaken method in that it uses a stream of nitrogen to provide agitation
rather than the rotationary movements.
Solution of lipid in chloroform: methanol mixture is spread over the flat bottom conical flask. The solution
is evaporated at room temperature by flow of nitrogen through the flask without disturbing the solution.
After drying water saturated nitrogen is passed through the flask untill the opacity of the dried film
disappears (15-20 mins).
After hydration, lipid is swelled by addition of bulk fluid. The flask is inclined to one side, 10-20ml of 0.2
sucrose in distilled water (degassed) is introduced down the slide of the flask ,and the flask is slowly
returned to upright orientation. The fluid is allowed to run gently over the lipid layer on the bottom of the
flasks.
Flask is flushed with nitrogen, sealed and allowed to stand for 2hours at 37 degrees Celsius. Take care not
to disturb the flask in any way.
After swelling, the vesicles are harvested by swirling the contents, to yield a milky –suspension.
1.Lipid film hydration by non shaking vesicles
37. 2. Microemulsification
Micro fluidizer is used to prepare small MLVs from
concentrated Lipid dispersion.
Micro fluidizer pumps the fluid at very at very high
pressure (10,000 psi), through a 5 micrometre orifice.
Then, it is forced along defined micro channels which
direct two streams of fluid collide together at the
right angles at a very high velocity, thereby affecting
an efficient transfer of energy.
The lipids can be introduced into the fluidizer, either
as large MLVs or as the slurry of a hydrated lipid in
organic medium. The fluid collected can be recycled
through the pump and the interaction chamber until
vesicles of spherical dimensions are obtained.
Diameter After a single pass, the size of vesicles is
reduced to a size 0.1 and 0.2um.
38. This is the method in which Multi lamellar
vesicles are transformed to the small unit
lamellar vesicles. The ultrasonic irradiation is
provided to the MLVs to get the SUVs.
There are two methods used.
a) Probe sonication method,
b) Bath sonication method.
The probe is employed for dispersion, which
requires high energy in a small volume (e.g.
High conc. of lipids or a viscous aqueous
phase) while is more suitable for large
volumes of diluted liquid.
Probe tip sonicator provides high energy
input to the liquid dispersion but suffer from
overheating of liposomal dispersion causing
lipid degradation.
3. Sonication method
39. 4. French Pressure Cell Method
This method is having the mechanism
of high pressure.
This method will give the either uni- or
oligo- lamellar Liposomes of
intermediate size (30- 80nm).
Liposomes are more stable compared
to the sonicated Liposomes.
Liposomes prepared by this method
having less structural defects unlike
sonicated liposome.
This method is having some drawbacks
are that initial high cost for the press
and the pressure cell
40. 5. Membrane Extrusion method
The technique can be used to process LUVs as well as MLVs.
The size of Liposomes is reduced by gently passing them
through a membrane filter of defined pore size achieved at
much lower pressure (<100psi)
In this process, the vesicle contents are exchanged with the
dispersion medium during the breaking and resealing of
phospholipids players as they pass through the
polycarbonate membrane.
The Liposomes produced by this technique have been
termed LUVETs.
41. 6. Dried Reconstituted vesicle
This method starts to freeze drying of
a dispersion of empty SUVs. After
freeze drying the freeze dried
membrane is obtained.
Then these freeze dried SUVs are
rehydrated with the use of aqueous
fluid containing the material to be
entrapped. This leads to the
formation of the solutes in uni- or
oligo- lamellar vesicles
42. This method is based upon freezing of
unilamellar dispersion (SUV). Then thawing
by standing at room temperature for 15min.
Finally subjecting to a brief Sonication cycle
which considerably reduces the permeability
of the Liposomes membrane.
In order to prepare GIANT VESICLES of
diameter between 10 and 50um, the freeze
thaw technique has been modified to
incorporate a dialysis step against hypo-
osmolar buffer in the place of sonication.
The method is simple, rapid and mild for
entrapped solutes, and results in a high
proportion of large unilamellar vesicle
formation which are useful for study of
membrane transport phenomenon.
7. Freeze Thaw Sonication
43. 1. Ethanol Injection Method
A lipid solution of ethanol is rapidly
injected to a vast excess of buffer. The
MLVs are immediately formed.
The drawbacks of the method are that
the population is heterogeneous (30-
110 nm), liposomes are very dilute, it is
difficult to remove all ethanol because
it forms azeotrope with water and the
possibility of various biologically active
macromolecules to inactivation in the
presence of even low amounts of
ethanol.
44. 2. Ether Injection Method
A solution of lipids dissolved in diethyl
ether or ether/methanol mixture is
slowly injected to an aqueous solution
of the material to be encapsulated at
55-65°C or under reduced pressure.
The subsequent removal of ether
under vacuum leads to the formation
of liposomes.
The main drawbacks of the method are
population is heterogeneous (70-190
nm) and the exposure of compounds
to be encapsulated to organic solvents
or high temperature
46. First water in oil emulsion is formed by brief
sonication of a two phase system containing
phospholipids in organic solvent (diethylether or
isopropylether or mixture of isopropyl ether and
chloroform) and aqueous buffer.
The organic solvents are removed under reduced
pressure, resulting in the formation of a viscous gel.
The liposomes are formed when residual solvent is
removed by continued rotary evaporation under
reduced pressure.
With this method high encapsulation efficiency up
to 65% can be obtained in a medium of low ionic
strength for example 0.01M NaCl.
The method has been used to encapsulate small
and large macromolecules.
The main disadvantage of the method is the
exposure of the materials to be encapsulated to
organic solvents and to brief periods of sonication
4. Reverse phase evaporation vesicles
47. The detergents at their critical micelles concentrations have been used to solubilize lipids. As
the detergent is removed the micelles become progressively richer in phospholipid and finally
combine to form LUVs.
The detergents can be removed by dialysis.
The advantages of detergent dialysis method are excellent reproducibility and production of
liposome populations which are homogenous in size.
The main drawback of the method is the retention of traces of detergent(s) within the
liposomes.
A commercial device called LIPOPREP (Diachema AG, Switzerland) which is a version of dialysis
system is available for the removal of detergents.
Other techniques have been used for the removal of detergents:
(a) by using Gel Chromatography involving a column of Sephadex G259
(b) by adsorption or binding of Triton X-100 (a detergent) to Bio-Beads SM-210 (c) by binding of octyl glucoside
(a detergent) to Amberlite XAD-2 beads.
Detergent Removal Method
48. The molecules of detergent are removed from mixed micelle by dialysis by lowering
the concentration of detergent in bulk aqueous phase.
eg: sodium cholate.
octylglucoside.
Dialysis Method
Column Chromatography
Removal of detergent is achieved by passing the dispersion over a sephadexg-25
column pre-saturated with constitutive lipids and pre-equilibrated with
hydrating buffer.
eg: deoxycholate.
49. In active loading, drug internalization into
preformed liposomes is typically driven
by a transmembrane pH gradient.
The pH outside the liposome allows some
of the drug to exist in an unionized form,
able to migrate across the lipid bilayer.
Once inside the liposome, the drug
becomes ionized due to the differing pH
and becomes trapped there
ACTIVE (REMOTE) LOADING
51. • Stabilization aspect for physical instability of liposomes
• Chemical stability
• Biological stability of liposomes
Stability Consideration
52. • Two different types of chemical degradation
• Oxidation of the unsaturated acyl chains,
• Hydrolysis of the ester bonds linking the fatty acids to the glycerol backbone
• The level of oxidation can be kept to a minimum by taking some precautions like
starting with freshly purified lipids and freshly distilled solvents, avoiding procedures
involving high temperatures, carrying out the manufacturing process in the absence of
oxygen, deoxygenating the aqueous solutions by passing nitrogen, storing all liposome
suspensions in an inert atmosphere and including an antioxidant, e.g. α-tocopherol, a
common non-toxic dietary lipid, as a component of the lipids membrane.
An alternative solution to the oxidation problem is to reduce the level of oxidizable lipids
in the membrane by using saturated lipids instead of the unsaturated ones.
Also, the mono-unsaturated ones have much less tendency of oxidation than the
polyunsaturated ones. Thus; sphingomyelins, usually having only one double bond, are
expected to degrade more slowly than other mammalian origin lipids.
Entirely synthetic and saturated phospholipids; DMPC, DPPC and DSPC, can also be
considered as a solution for the oxidative degradation of liposomes.
Chemical Stability:
53. • Hydrolysis type of chemical degradation of the ester linkages in the phospholipid structure
occurs most slowly at pH values close to neutral.
• In general, the rate of hydrolysis has a “V shaped” dependence, with a minimum at pH 6.5
and an increased rate at both higher and lower pH.
• In the active loading of drugs, low pH levels are required which triggers the hydrolysis. This
hydrolysis kind of chemical degradation is also very effective on the aqueous solutions of
liposome due to the presence of water.
• Temperature also triggers the hydrolysis of the lipids which creates the need for
refrigeration. In order to keep hydrolysis to a minimum during active loading, attention must
be paid for the removal of residual solvent from the dried lipids. To avoid hydrolysis, instead
of ester linked lipids, the usage of ether linkage containing lipids (e.g. found in the
membrane of halophilic bacteria) would be an absolute solution .Another chemical
degradation, oxidation of the lipids in the liposome structures can be prevented by the
addition of small amounts of antioxidants during the manufacturing steps.
Chemical Stability:
54. • The physical degradation, leakage and fusion of liposomes, can occur as a result of
the lattice defects in the membrane introduced during the manufacture,
particularly in SUVs that are prepared below the membrane phase transition
temperature.
• Annealing process, incubating the liposomes at a higher temperature than the
phase transition temperature, can wipe out these defects by equalizing the
differences in packing density between opposite sides of the bilayers.
• Even in annealed vesicles, aggregation and fusion can occur over a long period of
time.
• In neutral liposomes, aggregation takes place because of the van der Waals
interactions and because of the increased surface area it tends to be more
pronounced in large liposomes.
• The simplest solution to overcome this aggregation is to add a small amount of
negatively charged phospholipid (e.g. 10% PA or PG) to the liposome composition
Physical Stability:
55. • SUVs have much more tendency to fusion when compared to large liposomes due to the
presence of stress arising from the high curvature of the membrane.
• Since this can occur specifically at the transition temperature of the membrane, it would be
better to store these liposomes at a temperature much lower than the transition
temperature of the lipids.
• For example, SUVs should be stored above their transition temperature for no longer than
24 hours but LUVs can be stored for a longer period of time if the temperature of the
solution is kept in a range of 4-8 0C for approximately 1 week before the leakage of the
encapsulated material starts due to the hydrolytic degradation on the membrane structure .
• Also, addition of cholesterol to the phospholipid mixture would be a solution to reduce or
eliminate the transition.
• The presence of cholesterol prevents packing and aggregation by inducing orientation and
more rigidity to the phospholipids. Other than cholesterol, peptide incorporation to the lipid
membrane also enables the lipid membrane to be more rigid at physiological temperature.
• Permeability of liposome membranes depends highly on the membrane lipid composition,
as well as on the encapsulated material. Large polar or ionic molecules will be retained
much more efficiently than low molecular weight lipophilic compounds. Generally, for both
type of encapsulated material, a rigid, more saturated membrane with a higher ratio of
cholesterol forms the most stable lipid membrane concerning the leakage of the
encapsulated material.
Physical Stability:
56. • Biological liposome stability plays important roles at various stages of drug delivery. However, liposomes are
somewhat biologically unstable as a parenteral drug delivery system owing to their rapid uptake and clearance
from circulation by cells of the mononuclear phagocytic system (MPS) located mainly in the liver and spleen.
• Biological stability of liposomes is dependent on the presence of agents such as proteins that interact with
liposomes upon application to the subject and the administration route.
• There have been many strategies to enhance the biological stability of liposomes that improve the liposomal
drug delivery in vivo and increase the circulation time in blood stream.
• The complexation between polymers and liposomes has been studied as a way to increase the long-term
stability of liposomes.
• Grafting hydrophilic polymers onto the head groups of phospholipids, or the addition of water soluble polymers
containing several hydrophobic groups has been shown to increase the circulation time in vivo, as well as to
inhibit liposome fusion .
• These kinds of liposomes are called stealth liposome or sterically stabilized liposomes . The steric repulsion of
these liposomes stabilizes the liposomes against aggregation.
• One of the most popular and successful methods to obtain long-circulating biologically stable liposomes is to
coat the surface of the liposome with poly(ethylene glycol), PEG.
Biological Stability:
57. • It is important to estimate the amount of drug encapsulated within liposomes.
• This is easier to estimate by centrifugation in case of MLVs compared to LUVs and
SUVs.
• The various methods used to separate non-encapsulated drug are
• eg: Dialysis.
• Gel chromatography.
Removal of unentrapped drug from liposomes:
58. • For the characterization of chemical properties, phospholipids can be
quantitatively in terms of concentration either by Bartlett Assay or Stewart
Assay.
• The phospholipid hydrolysis might be followed by HPLC where the column
outflow can be monitored continuously by UV absorbance to obtain a
quantitative record of the eluted components.
• Moreover, the phospholipid oxidation can also be followed by a number of
techniques i.e.,
• UV absorbance method,
• TBA method (2-thiobarbutiric acid) (for endoperoxides),
• Iodometric method (for hydroperoxides) and
• GLC (gas-liquid chromatography) method.
Characterization of Liposome
59. Bartlett Assay
• The principle of the Bartlett assay is based on the colorimetric determination
of inorganic phosphate. The phospholipid content of liposomes can be
determined after destruction of the phospholipid with perchloric acid to
inorganic phosphate. The inorganic phosphate is converted to phospho-molybdic
acid by the addition of ammonium molybdate, which is reduced to a blue colored
complex by 4-amino-2-naphthyl-4-sulfonic acid during heating. This compound
can be determined colorimetrically at 830 nm.
Stewart Assay
• In Stewart assay, the phospholipid forms a complex with ammonium
ferrothiocyanate in organic solution. The advantage of this method is that the
presence of inorganic phosphate does not interfere with the assay.
60. • The most direct method for determination of liposome size is the electron microscopy due
to the possibility of viewing the liposomes individually and obtaining the exact information
about the liposome population over the whole range of sizes.
• As liposomes do not naturally create a contrast to be visible by electron microscopy,
either cryo-TEM should be used or staining of the liposome sample is required.
• Either way, it is a very time consuming method and it requires equipment's that may not
always be immediately accessible.
• The other method for the determination of liposome size, dynamic light scattering is very
simple and rapid to perform but it measures an average size of liposome bulk.
• More recently, atomic force microscopy is also used to determine the morphology, size
and stability of liposomal structures.
• All these size determination methods are very expensive.
• If only an approximate size range is required, gel exclusion chromatography might be
suitable.
Vesicle Size And Size Distribution:
61. • Electrostatic stabilization of liposomes may be a desirable feature to
prevent fusion.
• The surface charge on the liposomes is measured by zeta-potential
measurements.
• These measurements are useful in determination of the in vivo
behavior of liposomes.
• Often zeta potential values <-25 mV or >+25 mV are considered stable
• However, charged liposomes have the disadvantage of being unstable
in biological conditions.
Surface Charge:
62. • Membrane phospholipids undergo temperature dependent reversible
phase transitions from gel to liquid crystaline state.
• These have been documented by freeze fracture electron microscopy
and DSC.
• Tm of the phospholipid affects the membrane permeability, leakage
and stability of liposomes.
• Tm can be altered by using phospholipid mixtures or by adding
cholesterol.
Phase Behaviour of Liposomes:
63. • Entrapped volume is a crucial parameter that governs the morphology
of liposomes.
• This internal volume is defined as the aqueous entrapped volume per
unit quantity of lipids.
• The most promising way to determine the internal volume is to measure
the quantity of water by replacing external medium (water) with a
spectrophotometrically inert fluid (i.e. deuterium oxide) and then
measuring water signal by NMR
Entrapped volume of Liposomes:
64. • It is essential to measure the quantity of the encapsulated material
inside liposomal structures before studying the behavior of this
encapsulated material physically and biologically since the effects
observed experimentally will be dose related.
• After the removal of the nonencapsulated material by the separation
techniques the quantity of material remained can be assumed as 100%
encapsulated.
• Minicolumn centrifugation and protamine aggregation methods are the
general separation procedures that are commonly used
Encapsulation Efficiency:
65. • In vitro drug release from liposomal systems was determined using
dialysis sacks.
• Release test for a targeted liposome would need to show that
liposome is stable until uptake at the site.
In-vitro Drug Release
66. • Liposomes as drug or protein delivery vehicles.
• Liposome in antimicrobial, antifungal(lung therapeutics) and antiviral
(anti HIV) therapy.
• In tumour therapy.
• In gene therapy.
• In immunology.
• Liposomes as artificial blood surrogates.
• Liposomes as radiopharmaceutical and radiodiagnostic carriers.
• Liposomes in cosmetics and dermatology.
Application of Liposome